Found: 27
Select item for more details and to access through your institution.
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 12, p. 1429, doi. 10.1007/s40273-021-01073-y
- By:
- Publication type:
- Article
State of the ART? Two New Tools for Risk Communication in Health Technology Assessments.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 10, p. 1185, doi. 10.1007/s40273-021-01060-3
- By:
- Publication type:
- Article
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal".
- Published in:
- 2017
- By:
- Publication type:
- letter
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S026646232300260X
- By:
- Publication type:
- Article
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry.
- Published in:
- Quality of Life Research, 2020, v. 29, n. 12, p. 3363, doi. 10.1007/s11136-020-02604-4
- By:
- Publication type:
- Article
Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Letter
An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 9, p. 1123, doi. 10.1080/0284186X.2020.1775289
- By:
- Publication type:
- Article
Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 11, p. 1499, doi. 10.1080/0284186X.2018.1484156
- By:
- Publication type:
- Article
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review.
- Published in:
- Clinical Chemistry, 2021, v. 67, n. 1, p. 237, doi. 10.1093/clinchem/hvaa280
- By:
- Publication type:
- Article
Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 722, doi. 10.3390/cancers13040722
- By:
- Publication type:
- Article
Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230909
- By:
- Publication type:
- Article
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
- Published in:
- 2021
- By:
- Publication type:
- letter
The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00241
- By:
- Publication type:
- Article
Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
- Published in:
- 2021
- By:
- Publication type:
- Letter